Drug or chemical induced diabetes mellitus with other skin complications
ICD-10 E09.628 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with other skin complications.
Drug or chemical induced diabetes mellitus (E09) refers to diabetes that arises as a result of pharmacological agents or chemicals, often seen in patients undergoing treatment for other conditions. This specific code, E09.628, indicates the presence of additional skin complications associated with this form of diabetes. Skin complications can include infections, ulcers, and other dermatological issues that arise due to the altered metabolic state and impaired healing associated with diabetes. Patients may present with elevated HbA1c levels, indicating poor glycemic control, which can exacerbate skin conditions. Management often involves careful monitoring of blood glucose levels, insulin therapy, and addressing the skin complications through appropriate dermatological care. Understanding the interplay between the drug-induced diabetes and its complications is crucial for effective treatment and coding.
Detailed medication history, HbA1c levels, and treatment plans.
Patients with a history of cancer receiving chemotherapy that induces diabetes.
Ensure clear documentation of the relationship between the drug and diabetes onset.
Description of skin lesions, treatment provided, and response to treatment.
Patients presenting with diabetic ulcers or infections secondary to drug-induced diabetes.
Document the impact of diabetes on skin healing and management strategies.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any skin complications.
Endocrinologists should focus on medication adjustments and monitoring.
Common drugs include corticosteroids, certain antipsychotics, and some chemotherapy agents. These can affect insulin sensitivity or secretion.
